These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 20173444

  • 1. Early prediction of histopathological tumor response to preoperative chemotherapy by Tc-99m MIBI imaging in bone and soft tissue sarcomas.
    Taki J, Inaki A, Wakabayashi H, Sumiya H, Tsuchiya H, Zen Y, Kinuya S.
    Clin Nucl Med; 2010 Mar; 35(3):154-9. PubMed ID: 20173444
    [Abstract] [Full Text] [Related]

  • 2. Prediction of final tumor response to preoperative chemotherapy by Tc-99m MIBI imaging at the middle of chemotherapy in malignant bone and soft tissue tumors: comparison with Tl-201 imaging.
    Taki J, Higuchi T, Sumiya H, Tsuchiya H, Minato H, Tomita K, Tonami N.
    J Orthop Res; 2008 Mar; 26(3):411-8. PubMed ID: 17960652
    [Abstract] [Full Text] [Related]

  • 3. Prognostic value of Tc-99m-MIBI performed during middle course of preoperative chemotherapy in patients with malignant bone and soft-tissue tumors.
    Wakabayashi H, Taki J, Inaki A, Sumiya H, Zen Y, Tsuchiya H, Kinuya S.
    Clin Nucl Med; 2012 Jan; 37(1):1-8. PubMed ID: 22157020
    [Abstract] [Full Text] [Related]

  • 4. 99mTc-MIBI in the assessment of response to chemotherapy and detection of recurrences in bone and soft tissue tumours of the extremities.
    Moustafa H, Riad R, Omar W, Zaher A, Ebied E.
    Q J Nucl Med; 2003 Mar; 47(1):51-7. PubMed ID: 12714955
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. 99mTc-MIBI imaging as a predictor of therapy response in osteosarcoma compared with multidrug resistance-associated protein and P-glycoprotein expression.
    Burak Z, Moretti JL, Ersoy O, Sanli U, Kantar M, Tamgac F, Basdemir G.
    J Nucl Med; 2003 Sep; 44(9):1394-401. PubMed ID: 12960182
    [Abstract] [Full Text] [Related]

  • 9. [²⁰¹TI and (99m)Tc-MIBI scintigraphy in evaluation of neoadjuvant chemotherapy for osteosarcoma].
    Huang ZK, Lou C, Shi GH.
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2012 Mar; 41(2):183-7, 191. PubMed ID: 22499516
    [Abstract] [Full Text] [Related]

  • 10. Comparison of technetium-99m-MIBI and technetium-99m-tetrofosmin uptake by musculoskeletal sarcomas.
    Söderlund V, Jonsson C, Bauer HC, Brosjö O, Jacobsson H.
    J Nucl Med; 1997 May; 38(5):682-6. PubMed ID: 9170427
    [Abstract] [Full Text] [Related]

  • 11. The correlation of Tc-99m MIBI scintigraphy and histological response in determining the percentage of tumor necrosis in osteosarcoma after preoperative chemotherapy.
    Punyaratabandhu T, Wittayawongsaruji S, Rajchadara S, Thanakit V, Charoenvareekul S, Khunkitti N, Songpatanasilp T.
    J Med Assoc Thai; 2005 Nov; 88 Suppl 3():S53-62. PubMed ID: 16862675
    [Abstract] [Full Text] [Related]

  • 12. The role of 99mTc-MIBI scintigraphy in the assessment of MDR1 overexpression in patients with musculoskeletal sarcomas: comparison with therapy response.
    Burak Z, Ersoy O, Moretti JL, Erinç R, Ozcan Z, Dirlik A, Sabah D, Basdemir G.
    Eur J Nucl Med; 2001 Sep; 28(9):1341-50. PubMed ID: 11585293
    [Abstract] [Full Text] [Related]

  • 13. Evaluating benign and malignant bone and soft-tissue lesions with technetium-99m-MIBI scintigraphy.
    Taki J, Sumiya H, Tsuchiya H, Tomita K, Nonomura A, Tonami N.
    J Nucl Med; 1997 Apr; 38(4):501-6. PubMed ID: 9098190
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Double-phase Tc-99m MIBI scintigraphy as a therapeutic predictor in patients with non-Hodgkin's lymphoma.
    Song HC, Lee JJ, Bom HS, Chung IJ, Kim HJ, Park YK, Kim EE.
    Clin Nucl Med; 2003 Jun; 28(6):457-62. PubMed ID: 12911092
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A novel combined radiological method for evaluation of the response to chemotherapy for primary bone sarcoma.
    Miwa S, Taki J, Yamamoto N, Shirai T, Nishida H, Hayashi K, Tanzawa Y, Kimura H, Takeuchi A, Igarashi K, Ooi A, Tsuchiya H.
    J Surg Oncol; 2012 Sep 01; 106(3):273-9. PubMed ID: 22389049
    [Abstract] [Full Text] [Related]

  • 18. [99mTc-MAA perfusion studies in the treatment of preoperative intra-arterial infusion chemotherapy of malignant bone and soft tissue sarcoma].
    Satoh M, Takeuchi S, Kasai C, Kushida Y.
    Gan To Kagaku Ryoho; 1988 Aug 01; 15(8 Pt 2):2359-65. PubMed ID: 3415248
    [Abstract] [Full Text] [Related]

  • 19. Correlation of 99mTc-sestamibi uptake with blood-pool and osseous phase 99mTc-MDP uptake in malignant bone and soft-tissue tumours.
    Ozcan Z, Burak Z, Erinç R, Dirlik A, Başdemir G, Sabah D, Ozkiliç H.
    Nucl Med Commun; 2001 Jun 01; 22(6):679-83. PubMed ID: 11403180
    [Abstract] [Full Text] [Related]

  • 20. [Scintigraphy with 99mTc-MIBI for assessment of tumor response to preoperative chemotherapy in patients with osteosarcoma].
    García-Fernández R, Hernández-Hernández DM, Iwasaki-Otake L, Mantilla-Morales A, Ortiz-Rodríguez L, Pichardo-Romero P, Lira-Puerto V.
    Rev Invest Clin; 2001 Jun 01; 53(4):324-9. PubMed ID: 11599479
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.